Page last updated: 2024-08-24

triazoles and Candidiasis, Oral

triazoles has been researched along with Candidiasis, Oral in 51 studies

Research

Studies (51)

TimeframeStudies, this research(%)All Research%
pre-199011 (21.57)18.7374
1990's13 (25.49)18.2507
2000's19 (37.25)29.6817
2010's8 (15.69)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dastgheib, L; Ghasemi, N; Jowkar, F; Nouraei, H; Pakshir, K; Zomorodian, K1
Eraso, E; Gil-Alonso, S; Jauregizar, N; Marcos-Arias, C; Mateo, E; Quindós, G; Sevillano, E1
Dassanayake, RS; Ellepola, ANB; Khan, Z1
Bulacio, L; Escovich, L; López, C; Pairoba, C; Paz, M; Ramadán, S; Ramos, L; Sortino, M1
Hancianu, M; Kolecka, A; Marangoci, N; Mares, M; Minea, B; Nastasa, V; Pinteala, M; Rosca, I1
Brusca, MI; Iovannitti, CA; Jewtuchowicz, VM; Malzone, MC; Mujica, MT; Pola, SJ; Rosa, AC; Sordelli, N1
Aguirre, JM; Carrillo-Muñoz, AJ; Eraso, E; Gaitán-Cepeda, LA; Quindós, G; Sánchez Vargas, LO1
Nweze, EI; Ogbonnaya, UL1
Berghs, HAM; Carvalho, LR; Kacew, S; Martins, MA; Melhem, MSC; Mendes, RP; Moris, DV; Pimenta-Rodrigues, MV; Souza, LR; Szeszs, MW1
Albougy, HA; Naidoo, S1
Brown, N; Chau, AS; DiDomenico, B; Hare, RS; Li, X; Loebenberg, D; López-Ribot, JL; McNicholas, PM; Mendrick, CA; Quindos, G; Ruesga, MT1
Chau, AS; Loebenberg, D; McNicholas, PM; Mendrick, CA; Sabatelli, FJ1
Andreadis, D; Antoniades, D; Arsenis, G; Belazi, M; Destouni, E; Eliopoulou, C; Hini, S; Koussidou-Eremondi, T; Velegraki, A1
Burn, AK; Coco, BJ; Fothergill, AW; Kirkpatrick, WR; McCarthy, DI; Patterson, TF; Redding, SW; Rinaldi, MG1
Alonso, R; Carrillo-Muñoz, AJ; del Valle, O; Hernández-Molina, JM; Loebenberg, D; McNicholas, P; Quindós, G; Ruesga, M; Santos, P1
Coco, BJ; Fothergill, AW; Kirkpatrick, WR; Oliveira, ER; Patterson, TF; Redding, SW1
Bagg, J; Coulter, WA; Kuriyama, T; Lewis, MA; Ready, D; Williams, DW1
Gogate, J; Greaves, W; Isaacs, R; Nieto, L; Northland, R; Sanne, I; Skiest, DJ; Vazquez, JA1
Klotz, SA1
Anstead, GM; Boparai, N; Graybill, JR; Hare, R; Isaacs, R; Reynes, J; Skiest, DJ; Vazquez, JA; Ward, D1
Kalavsky, E; Krcmery, V; Liskova, A; Shahum, A1
Vazquez, JA1
Bourolias, CA; Karatzanis, AD; Kofteridis, DP; Mantadakis, E; Papazoglou, G; Samonis, G; Velegrakis, GA1
Givner, LB; Horn, CA; Peacock, JE; Pegram, PS; Washburn, RG1
Barchiesi, F; Colombo, AL; Fothergill, AW; McGough, DA; Rinaldi, MG1
Bastide, JM; Janbon, F; Le Guennec, R; Mallié, M; Pujol, C; Reynes, J1
Hata, K; Katsu, K; Kimura, J; Miki, H; Moriyama, M; Toyosawa, T1
Ruhnke, M; Schmidt-Westhausen, A; Trautmann, M1
Hernanz Hermosa, JM; Lázaro Ochaita, P1
Gubbins, PO; Penzak, SR1
Cartledge, JD; Clumeck, N; De Wit, S; Denning, DW; Dupont, B; Gazzard, BG; Hawkins, DA; Midgley, J1
Cantu, RA; Fothergill, AW; Kirkpatrick, WR; Lopez-Ribot, JL; Mcatee, RK; McCarthy, DI; Patterson, TF; Revankar, SG; Rinaldi, MG; Sanche, SE1
Diehl, V; Fätkenheuer, G; Hegener, P; Ruhnke, M; Troke, PF1
Atkinson, G; Denning, DW; Hollis, S; Hood, SV; Percy, M; Williams, K1
Bernal, S; Chávez, M; Gutierrez, MJ; Mazuelos, EM; Quindós, G; Valverde, A1
Ellepola, AN; Samaranayake, LP2
Graybill, JR; Hardin, TC; Lam, YF; Rinaldi, MG; Sharkey, PK; Wallace, JE1
Bille, J; Cajot, A; Chave, JP; Glauser, MP1
Dietrich, D1
Adachi, M; Ikeda, H; Kawanishi, M; Matsushima, T; Nakamura, J; Tanabe, J; Tano, Y; Tomizawa, S1
Lamey, PJ; Lewis, MA; MacDonald, DG1
Martin, MV1
Clumeck, N; De Wit, S; Goossens, H; Weerts, D1
Clements, D; Holmes, J1
Drouhet, E; Dupont, B2
Budtz-Jørgensen, E; Holmstrup, P; Krogh, P1

Reviews

6 review(s) available for triazoles and Candidiasis, Oral

ArticleYear
Therapeutic tools for oral candidiasis: Current and new antifungal drugs.
    Medicina oral, patologia oral y cirugia bucal, 2019, Mar-01, Volume: 24, Issue:2

    Topics: Administration, Intravenous; Administration, Oral; Administration, Topical; Amphotericin B; Anidulafungin; Antifungal Agents; Azoles; Candidiasis, Oral; Caspofungin; Clotrimazole; Databases, Factual; Drug Interactions; Echinocandins; Fluconazole; Humans; Miconazole; Nitriles; Nystatin; Pyridines; Triazoles

2019
A systematic review of the management of oral candidiasis associated with HIV/AIDS.
    SADJ : journal of the South African Dental Association = tydskrif van die Suid-Afrikaanse Tandheelkundige Vereniging, 2002, Volume: 57, Issue:11

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Comorbidity; HIV Infections; Humans; Practice Guidelines as Topic; Treatment Outcome; Triazoles

2002
[Superficial mycoses in immunosuppressed patients].
    Revista clinica espanola, 1995, Volume: 195 Suppl 3

    Topics: Adult; Antifungal Agents; Candidiasis, Cutaneous; Candidiasis, Oral; Candidiasis, Vulvovaginal; Child; Dermatitis, Seborrheic; Dermatomycoses; Female; Fluconazole; Humans; Imidazoles; Immunosuppression Therapy; Itraconazole; Ketoconazole; Male; Morpholines; Onychomycosis; Tinea; Tinea Versicolor; Transplantation; Triazoles

1995
Preventing and treating azole-resistant oropharyngeal candidiasis in HIV-infected patients.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998, Feb-01, Volume: 55, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Itraconazole; Triazoles

1998
Antimycotic agents in oral candidosis: an overview: 1. Clinical variants.
    Dental update, 2000, Volume: 27, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candidiasis, Oral; Cheilitis; Drug Resistance, Microbial; Glossitis; Humans; Immunocompromised Host; Opportunistic Infections; Stomatitis, Denture; Treatment Outcome; Triazoles

2000
Oral candidal infections and antimycotics.
    Critical reviews in oral biology and medicine : an official publication of the American Association of Oral Biologists, 2000, Volume: 11, Issue:2

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Anti-Infective Agents, Local; Antifungal Agents; Candida; Candidiasis, Oral; Chlorhexidine; Clotrimazole; Drug Resistance, Fungal; Fluconazole; Flucytosine; Humans; Immunocompromised Host; Itraconazole; Ketoconazole; Miconazole; Mouth; Nystatin; Opportunistic Infections; Saliva; Treatment Failure; Triazoles

2000

Trials

6 trial(s) available for triazoles and Candidiasis, Oral

ArticleYear
A multicenter randomized trial evaluating posaconazole versus fluconazole for the treatment of oropharyngeal candidiasis in subjects with HIV/AIDS.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Apr-15, Volume: 42, Issue:8

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candidiasis; Candidiasis, Oral; Double-Blind Method; Ethnicity; Female; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Pharyngeal Diseases; Probability; Treatment Outcome; Triazoles

2006
Posaconazole for the treatment of azole-refractory oropharyngeal and esophageal candidiasis in subjects with HIV infection.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2007, Feb-15, Volume: 44, Issue:4

    Topics: Administration, Oral; Adult; AIDS-Related Opportunistic Infections; Candidiasis; Candidiasis, Oral; Confidence Intervals; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Resistance, Fungal; Esophageal Diseases; Female; Fluconazole; Follow-Up Studies; Humans; Itraconazole; Male; Middle Aged; Probability; Severity of Illness Index; Treatment Failure; Treatment Outcome; Triazoles

2007
Treatment of HIV-related fluconazole-resistant oral candidosis with D0870, a new triazole antifungal.
    AIDS (London, England), 1998, Mar-05, Volume: 12, Issue:4

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; Humans; Male; Microbial Sensitivity Tests; Pilot Projects; Treatment Outcome; Triazoles

1998
Assessment of therapeutic response of oropharyngeal and esophageal candidiasis in AIDS with use of a new clinical scoring system: studies with D0870.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 1999, Volume: 28, Issue:3

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Colony Count, Microbial; Drug Resistance, Microbial; Esophageal Diseases; Fluconazole; Humans; Microbial Sensitivity Tests; Prospective Studies; Treatment Outcome; Triazoles

1999
Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS.
    Lancet (London, England), 1989, Apr-08, Volume: 1, Issue:8641

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; AIDS-Related Complex; Candidiasis, Oral; Clinical Trials as Topic; Double-Blind Method; Female; Fluconazole; Follow-Up Studies; Humans; Ketoconazole; Male; Middle Aged; Oropharynx; Pharyngeal Diseases; Prospective Studies; Recurrence; Triazoles

1989
Fluconazole in the treatment of Candida-associated denture stomatitis.
    Antimicrobial agents and chemotherapy, 1988, Volume: 32, Issue:12

    Topics: Aged; Candidiasis, Oral; Clinical Trials as Topic; Double-Blind Method; Female; Fluconazole; Humans; Male; Middle Aged; Stomatitis; Stomatitis, Denture; Triazoles; Yeasts

1988

Other Studies

39 other study(ies) available for triazoles and Candidiasis, Oral

ArticleYear
Identification and Antifungal Activity Profile of Candida Species Isolated from Patients with Pemphigus Vulgaris with Oral Lesions.
    Acta dermatovenerologica Croatica : ADC, 2019, Volume: 27, Issue:3

    Topics: Adult; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Disk Diffusion Antimicrobial Tests; Econazole; Female; Fluconazole; Humans; Itraconazole; Ketoconazole; Male; Pemphigus; Triazoles

2019
In vitro Post-Antifungal Effect of Posaconazole and Its Impact on Adhesion-Related Traits and Hemolysin Production of Oral Candida dubliniensis Isolates.
    Medical principles and practice : international journal of the Kuwait University, Health Science Centre, 2019, Volume: 28, Issue:6

    Topics: Antifungal Agents; Candida; Candidiasis, Oral; Cell Adhesion; Hemolysin Proteins; In Vitro Techniques; Microbial Sensitivity Tests; Triazoles

2019
Oral infections caused by yeasts in patients with head and neck cancer undergoing radiotherapy. Identification of the yeasts and evaluation of their antifungal susceptibility.
    Journal de mycologie medicale, 2012, Volume: 22, Issue:4

    Topics: Amphotericin B; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Fungal; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Mycoses; Naphthalenes; Nystatin; Opportunistic Infections; Saccharomyces cerevisiae; Species Specificity; Terbinafine; Triazoles

2012
Etiologic Agents and Antifungal Susceptibility of Oral Candidosis from Romanian patients with HIV-infection or type 1 diabetes mellitus.
    Polish journal of microbiology, 2016, Volume: 65, Issue:1

    Topics: Antifungal Agents; Candida; Candidiasis, Oral; Diabetes Complications; Diabetes Mellitus, Type 1; Drug Resistance, Fungal; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Romania; Triazoles

2016
Phenotypic and genotypic identification of Candida dubliniensis from subgingival sites in immunocompetent subjects in Argentina.
    Oral microbiology and immunology, 2008, Volume: 23, Issue:6

    Topics: Adolescent; Adult; Aged; Argentina; Candida; Candidiasis, Oral; Dental Plaque; DNA, Fungal; Drug Resistance, Fungal; Female; Fluconazole; Genotype; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Periodontal Pocket; Phenotype; Polymerase Chain Reaction; Pyrimidines; Triazoles; Voriconazole; Young Adult

2008
In vitro activity of voriconazole against Mexican oral yeast isolates.
    Mycoses, 2010, Volume: 53, Issue:3

    Topics: Adult; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; HIV Infections; Humans; Mexico; Microbial Sensitivity Tests; Mouth; Pharynx; Pyrimidines; Triazoles; Voriconazole

2010
Posaconazole: new indications. Prevention of invasive mycosis and treatment of oropharyngeal candidiasis: no therapeutic advantage.
    Prescrire international, 2008, Volume: 17, Issue:98

    Topics: Antifungal Agents; Candidiasis, Oral; Drug Approval; Europe; Humans; Mycoses; Randomized Controlled Trials as Topic; Triazoles

2008
Oral Candida isolates among HIV-infected subjects in Nigeria.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2011, Volume: 44, Issue:3

    Topics: Adult; Aged; AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Drug Resistance, Fungal; Female; Fluconazole; Flucytosine; HIV Infections; Humans; Itraconazole; Male; Microbial Sensitivity Tests; Middle Aged; Mycological Typing Techniques; Nigeria; Pyrimidines; Triazoles; Voriconazole

2011
Prevalence and antifungal susceptibility of Candida parapsilosis complex isolates collected from oral cavities of HIV-infected individuals.
    Journal of medical microbiology, 2012, Volume: 61, Issue:Pt 12

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Caspofungin; Echinocandins; Female; Fluconazole; HIV Infections; Humans; Lipopeptides; Male; Microbial Sensitivity Tests; Mouth; Mycological Typing Techniques; Polymorphism, Restriction Fragment Length; Pyrimidines; Triazoles; Voriconazole

2012
Changes in susceptibility to posaconazole in clinical isolates of Candida albicans.
    The Journal of antimicrobial chemotherapy, 2004, Volume: 53, Issue:1

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Fungal; Genes, Viral; HIV Infections; Humans; Microbial Sensitivity Tests; Mutation; Triazoles

2004
Application of real-time quantitative PCR to molecular analysis of Candida albicans strains exhibiting reduced susceptibility to azoles.
    Antimicrobial agents and chemotherapy, 2004, Volume: 48, Issue:6

    Topics: Actins; Antifungal Agents; Azoles; Candida albicans; Candidiasis, Oral; Cloning, Molecular; Computer Systems; DNA-Binding Proteins; DNA, Fungal; Drug Resistance, Fungal; Fungal Proteins; Gene Expression Regulation, Fungal; Microbial Sensitivity Tests; Mutation; Oropharynx; Proton-Translocating ATPases; Reverse Transcriptase Polymerase Chain Reaction; Saccharomyces cerevisiae Proteins; Species Specificity; Transcription, Genetic; Triazoles

2004
Oral Candida isolates in patients undergoing radiotherapy for head and neck cancer: prevalence, azole susceptibility profiles and response to antifungal treatment.
    Oral microbiology and immunology, 2004, Volume: 19, Issue:6

    Topics: Adult; Aged; Antifungal Agents; Azoles; Candida; Candidiasis, Oral; Carcinoma, Squamous Cell; Cranial Irradiation; Drug Resistance, Fungal; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Mouth Mucosa; Mouth Neoplasms; Pyrimidines; Stomatitis; Triazoles; Voriconazole

2004
Comparison of antifungal susceptibilities to fluconazole and voriconazole of oral Candida glabrata isolates from head and neck radiation patients.
    Journal of clinical microbiology, 2004, Volume: 42, Issue:12

    Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Fluconazole; Head and Neck Neoplasms; Humans; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole

2004
Antifungal activity of posaconazole compared with fluconazole and amphotericin B against yeasts from oropharyngeal candidiasis and other infections.
    The Journal of antimicrobial chemotherapy, 2005, Volume: 55, Issue:3

    Topics: Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Humans; Microbial Sensitivity Tests; Triazoles

2005
In vitro interaction of posaconazole and caspofungin against clinical isolates of Candida glabrata.
    Antimicrobial agents and chemotherapy, 2005, Volume: 49, Issue:8

    Topics: Antifungal Agents; Candida glabrata; Candidiasis, Oral; Caspofungin; Drug Resistance, Fungal; Drug Synergism; Echinocandins; Fluconazole; Humans; Lipopeptides; Microbial Sensitivity Tests; Peptides, Cyclic; Triazoles

2005
In vitro susceptibility of oral Candida to seven antifungal agents.
    Oral microbiology and immunology, 2005, Volume: 20, Issue:6

    Topics: Amphotericin B; Antifungal Agents; Candida; Candida albicans; Candida glabrata; Candida tropicalis; Candidiasis, Oral; Drug Resistance, Fungal; Fluconazole; Humans; Itraconazole; Ketoconazole; Miconazole; Mouth Diseases; Nystatin; Pyrimidines; Triazoles; Voriconazole

2005
Oropharyngeal candidiasis: a new treatment option.
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2006, Apr-15, Volume: 42, Issue:8

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis; Candidiasis, Oral; Clinical Trials as Topic; Humans; Pharyngeal Diseases; Triazoles

2006
Posaconazole (Noxafil) for invasive fungal infections.
    The Medical letter on drugs and therapeutics, 2006, Nov-20, Volume: 48, Issue:1248

    Topics: Antifungal Agents; Candidiasis, Oral; Drug Interactions; Humans; Mycoses; Triazoles

2006
Voriconazole resistant Candida spp. and Saccharomyces spp. isolates from oropharyngeal candidiasis from Cambodian children with AIDS not pretreated with azoles (letter).
    Scandinavian journal of infectious diseases, 2007, Volume: 39, Issue:3

    Topics: Acquired Immunodeficiency Syndrome; AIDS-Related Opportunistic Infections; Antifungal Agents; Azoles; Cambodia; Candida; Candidiasis, Oral; Child; Drug Resistance, Multiple, Fungal; Humans; Oropharynx; Pharyngeal Diseases; Pyrimidines; Saccharomyces; Triazoles; Voriconazole

2007
Posaconazole for the management of mucosal candidiasis.
    Future microbiology, 2007, Volume: 2, Issue:3

    Topics: Antifungal Agents; Antiretroviral Therapy, Highly Active; Candidiasis, Oral; HIV Infections; Humans; Molecular Structure; Randomized Controlled Trials as Topic; Triazoles

2007
Non-Candida albicans Candida mediastinitis of odontogenic origin in a diabetic patient.
    Medical mycology, 2008, Volume: 46, Issue:4

    Topics: Adult; Amphotericin B; Antifungal Agents; Candidiasis, Oral; Diabetes Mellitus, Type 2; Female; Humans; Mediastinitis; Opportunistic Infections; Pyrimidines; Triazoles; Voriconazole

2008
Azole-resistant oropharyngeal and esophageal candidiasis in patients with AIDS.
    AIDS (London, England), 1995, Volume: 9, Issue:5

    Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Amphotericin B; Candidiasis; Candidiasis, Oral; Child, Preschool; Drug Resistance, Microbial; Esophageal Diseases; Female; Humans; Male; Middle Aged; Triazoles

1995
In vitro activity of a new antifungal triazole, D0870, against Candida albicans isolates from oral cavities of patients infected with human immunodeficiency virus.
    Antimicrobial agents and chemotherapy, 1994, Volume: 38, Issue:11

    Topics: AIDS-Related Opportunistic Infections; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests; Stereoisomerism; Triazoles

1994
Fluconazole- and itraconazole-resistant Candida albicans strains from AIDS patients: multilocus enzyme electrophoresis analysis and antifungal susceptibilities.
    Journal of clinical microbiology, 1995, Volume: 33, Issue:10

    Topics: Acquired Immunodeficiency Syndrome; Adult; Alleles; Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Electrophoresis; Enzymes; Fluconazole; Humans; Itraconazole; Microbial Sensitivity Tests; Triazoles

1995
Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis.
    Antimicrobial agents and chemotherapy, 1996, Volume: 40, Issue:10

    Topics: Animals; Antifungal Agents; Aspergillosis; Brain Diseases; Candidiasis; Candidiasis, Oral; Cryptococcosis; Female; Fluconazole; Lung Diseases, Fungal; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Rats; Rats, Sprague-Dawley; Thiazoles; Triazoles

1996
In vitro activities of voriconazole (UK-109,496) against fluconazole-susceptible and -resistant Candida albicans isolates from oral cavities of patients with human immunodeficiency virus infection.
    Antimicrobial agents and chemotherapy, 1997, Volume: 41, Issue:3

    Topics: Antifungal Agents; Candida albicans; Candidiasis, Oral; Drug Resistance, Microbial; Fluconazole; HIV Infections; Humans; Microbial Sensitivity Tests; Mouth; Pyrimidines; Triazoles; Voriconazole

1997
Detection of Candida dubliniensis in oropharyngeal samples from human immunodeficiency virus-infected patients in North America by primary CHROMagar candida screening and susceptibility testing of isolates.
    Journal of clinical microbiology, 1998, Volume: 36, Issue:10

    Topics: AIDS-Related Opportunistic Infections; Amphotericin B; Antifungal Agents; Candida; Candidiasis, Oral; Fluconazole; Genotype; HIV Infections; Humans; Itraconazole; Microbial Sensitivity Tests; Mouth; North America; Pharynx; Phenotype; Pyrimidines; Triazoles; Voriconazole

1998
Treatment of fluconazole-resistant candidiasis with voriconazole in patients with AIDS.
    AIDS (London, England), 1998, Nov-12, Volume: 12, Issue:16

    Topics: Acquired Immunodeficiency Syndrome; Administration, Oral; Adult; Aged; Antifungal Agents; Candidiasis, Oral; Drug Resistance, Microbial; Female; Fluconazole; Humans; Male; Middle Aged; Pyrimidines; Triazoles; Voriconazole

1998
In-vitro activity of voriconazole (UK-109,496), LY303366 and other antifungal agents against oral Candida spp. isolates from HIV-infected patients.
    The Journal of antimicrobial chemotherapy, 1999, Volume: 44, Issue:5

    Topics: AIDS-Related Opportunistic Infections; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Oral; Echinocandins; Microbial Sensitivity Tests; Peptides, Cyclic; Pyrimidines; Triazoles; Voriconazole

1999
Pharmacokinetics of SCH-39304 in human immunodeficiency virus-infected patients following chronic oral dosing.
    Antimicrobial agents and chemotherapy, 1992, Volume: 36, Issue:12

    Topics: Administration, Oral; Adult; Antifungal Agents; Candidiasis, Oral; Drug Administration Schedule; HIV Infections; HIV-1; Humans; Male; Middle Aged; Triazoles

1992
Single-dose therapy for oral candidiasis with fluconazole in HIV-infected adults: a pilot study.
    The Journal of infectious diseases, 1989, Volume: 159, Issue:4

    Topics: Acquired Immunodeficiency Syndrome; Antifungal Agents; Candidiasis, Oral; Fluconazole; Humans; Pilot Projects; Triazoles

1989
[AIDS: bad prognosis in candidiasis. Cryptococcosis in brain involvement is usually fatal--experiences with a new therapeutic drug].
    Fortschritte der Medizin, 1989, Mar-15, Volume: 107, Issue:8

    Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Meningitis; Opportunistic Infections; Prognosis; Triazoles

1989
[Clinical evaluation of fluconazole in patients with mycotic infection].
    The Japanese journal of antibiotics, 1989, Volume: 42, Issue:1

    Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Aspergillus; Candidiasis; Candidiasis, Oral; Drug Evaluation; Female; Fluconazole; Humans; Lung; Lung Diseases, Fungal; Male; Microbial Sensitivity Tests; Mycoses; Sepsis; Tissue Distribution; Triazoles

1989
Treatment of candidal leukoplakia with fluconazole.
    British dental journal, 1989, Apr-22, Volume: 166, Issue:8

    Topics: Antifungal Agents; Candidiasis, Oral; Cheilitis; Fluconazole; Humans; Male; Middle Aged; Triazoles

1989
A comparison of fluconazole and ketoconazole in the treatment of rat palatal candidosis.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1989, Volume: 27, Issue:2

    Topics: Animals; Antifungal Agents; Candidiasis, Oral; Epithelium; Fluconazole; Image Processing, Computer-Assisted; Ketoconazole; Male; Microcomputers; Palate; Rats; Rats, Inbred Strains; Triazoles

1989
Jaundice in HIV positive haemophiliac.
    Lancet (London, England), 1989, May-06, Volume: 1, Issue:8645

    Topics: Adult; Antifungal Agents; Candidiasis, Oral; Fluconazole; Hemophilia A; HIV Seropositivity; Humans; Jaundice; Liver Function Tests; Male; Triazoles

1989
Fluconazole versus ketoconazole in oropharyngeal candidiasis in AIDS.
    Lancet (London, England), 1989, May-20, Volume: 1, Issue:8647

    Topics: Acquired Immunodeficiency Syndrome; Candidiasis, Oral; Female; Fluconazole; Humans; Ketoconazole; Male; Pharyngeal Diseases; Triazoles

1989
Fluconazole in the management of oropharyngeal candidosis in a predominantly HIV antibody-positive group of patients.
    Journal of medical and veterinary mycology : bi-monthly publication of the International Society for Human and Animal Mycology, 1988, Volume: 26, Issue:1

    Topics: Adult; Aged; Candida albicans; Candidiasis; Candidiasis, Oral; Female; Fluconazole; HIV Seropositivity; Humans; Male; Middle Aged; Pharyngeal Diseases; Time Factors; Triazoles

1988
Fluconazole for the treatment of fungal diseases in immunosuppressed patients.
    Annals of the New York Academy of Sciences, 1988, Volume: 544

    Topics: Acquired Immunodeficiency Syndrome; Adult; Antifungal Agents; Candidiasis, Oral; Cryptococcosis; Fluconazole; Humans; Immunosuppression Therapy; Kidney Transplantation; Meningitis; Triazoles

1988